Skip to content
The Fort Worth

Rutledge Cancer Foundation’s $1.5 Million ACES Grant Fuels Groundbreaking Research to Advance New Treatments for Ewing Sarcoma

FORT WORTH, Texas — August 2026 — Rutledge Cancer Foundation (RCF) is advancing an ambitious new approach to Ewing sarcoma research through its $1.5 million ACES Grant (Advancing Cures for Ewing Sarcoma), a three-year initiative bringing together leading researchers from John Hopkins and National In

Sources and story details